DELTA-FLY PHARM

#620 COMPANY RANKING
Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323 to treat lung cancer; DFP-17729, DFP-11207, and DFP-14927 for the treatment of solid tumors; and DFP-10825 for peritoneal metastasis. The company was founded in 2010 and is headquartered in Tokushima, Japan.

Delta-Fly Pharm's stories on HackerNoon

Technology evolves every day, impacting our lives more and more. Don’t miss out on the tech of tomorrow via these remarkable technology stories.

Delta-Fly Pharm's latest news & mentions

Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.

Representing this company? Click here to claim and customize this page!

Reviews About Delta-Fly Pharm

avatar

Delta-Fly Pharm WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!